Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5182)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 15, 2022 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Quentin V, Singh M, Nguyen LS. A review of potential mechanisms and uses of SGLT2 inhibitors in ischemia-reperfusion phenomena. World J Diabetes 2022; 13(9): 683-695 [PMID: 36188147 DOI: 10.4239/wjd.v13.i9.683] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v13/i9/683.htm |
| Number | Citing Articles |
| 1 |
Danúbia Silva dos Santos, Lauro Thiago Turaça, Keyla Cristiny da Silva Coutinho, Raiana Andrade Quintanilha Barbosa, Juliano Zequini Polidoro, Tais Hanae Kasai-Brunswick, Antonio Carlos Campos de Carvalho, Adriana Castello Costa Girardi. Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-35944-5
|